PB Fintech. Q3 FY26 Earnings Analysis

- New initiatives currently constitute about 7.5% of total Contribution; expected to reach near adj. EBITDA zero by FY27, indicating breakeven and profitability growth. - Core business expected to continue its robust growth and profitability, with unique economics that improve over time. - PoSP (Point of Sale Person) channel growth is expected to stabilize at similar rates, largely driven by Motor insurance but increasingly diversified. - Health and Term insurance growth driven by addition of new customers, not tricks in pricing; narrow network products expected to add extra growth. - Management targets ₹1 trillion premium scale, with associated 2-3% profit margin range, aiming for sustainable premium growth rather than focusing solely on margins. - UAE business has turned profitable with 64% YoY premium growth, aligned with Health and Life focus. - Overall, focus remains on top-line revenue growth rather than short-term margin improvements.

- New initiatives aim to be close to zero losses by FY27 at Contribution level, indicating improving unit economics and potential profit contribution. - Management expects PoSP business losses to become meaningless by next year (FY27), suggesting breakeven or profitability soon. - Contribution margin on new initiatives was 5.5% for the quarter, showing positive directional movement. - Indirect costs expected to grow roughly half the rate of revenue growth, indicating controlled expense growth. - Consolidated PAT margin improved significantly to 8% with PAT growing 2.65x YoY, showing strong profitability momentum. - Management targets ₹1,000 Cr profit next year (FY27); New initiatives fluctuations expected to cause minimal impact (+/-2%). - Long-term goal is to reach around 3% profit margin on premiums by FY30. - ESOP payouts to remain steady without major change impacting earnings. - Overall focus remains on growth over near-term profit maximization, balancing scale and profitability.

- Four healthcare facilities have been part acquired as part of the PB Health initiative. - The focus is on building a narrow healthcare network with care pathways and integrated technology, which is a slow and steady process. - On New initiatives like PB Money and Pensionbazaar, investments so far have been minimal (less than half a million dollars) and currently remain at the drawing board/testing stage. - Future capital or strategic investments may occur when management is confident about the business approach. - The company maintains a strategy of investing in growth segments and new business units, including technology and product development, implying ongoing fixed cost investments. - No specific large-scale capex numbers or timelines were disclosed, but investments align with expanding and scaling new segments and technology capabilities.

- There is no specific mention of any current or planned new fundraising through debt or equity in the provided transcript. - Management focuses on growth and investments in new initiatives but does not indicate any upcoming equity or debt issuance. - Investments in new initiatives like Pensionbazaar and PB Money are currently minimal and at the drawing board stage, implying no major fundraising needs yet. - The company emphasizes managing costs and profitability without signaling a requirement for fresh fundraising. - For further questions or clarifications, investors are encouraged to contact investor.relations@pbfintech.in.

The transcript does not explicitly mention current or expected order book or pending orders. However, relevant points related to business momentum and growth include: - Total premium for the quarter is ₹7,605 Cr, up 40% YoY. - Consolidated revenue grew 38% YoY to ₹1,614 Cr for the quarter. - Renewal trail revenue on a 12-month rolling basis is ₹774 Cr. - QoQ Core Credit revenue was up 4%, with disbursals growth at 9%, indicating stabilization. - PB Partners platform is consolidating leadership with over 380K advisors across 19k PIN codes. - New initiatives like Pensionbazaar and PB Money remain at the drawing board stage with minimal incremental investments. - Growth continues in core insurance premiums at 39% YoY, excluding the Savings category. - PB Health's narrow network and hospital acquisitions are progressing slowly as part of a long-term strategy. No direct data on order book or pending orders is provided.